m a p s • v o l u m e x i i i n u m b e r 2 • w i n t e r 2 0 0 3
placed it in limbo. However, medicallysupervised, government-licensedibogaine treatment is currently avail-able at the Healing Visions clinic, lo-cated in St. Kitts, West Indies, whereDr. Deborah Mash is the Director of Re-search. Unlicensed treatment is alsooffered at centers in Mexico, Canada,and Italy.In response to the growingmountain of anecdotal evidence at-testing to its efficacy, an informal underground treatment network has risen, witha variety of individuals offering ibogaine itself (HCl, extract, whole root, and pretty much ev-erything in between), to treatment of drug de-pendence using ibogaine.The use of ibogaine as an entheogen —for attaining greater self knowledge and/or unionwith the divine — is also on the rise, with anactual religion (Sacrament of Transition) recentlybeen established in Slovenia.Worldwide awareness and availability of ibogaine have continued to steadily increase,with a significant burst of exposure in the massmedia over the last year. Articles on ibogainehave appeared in the
New York Times,
Jour-nal of the American Medical Association
and otherpublications.The following paper describes a series of ibogaine treatments that were facilitated in 2001and 2002. The program took place in the tran-quil surroundings of The Farm, West Sussex, U.K.The facility used was a converted soundproof studio — formerly a recording studio — sepa-rate from the main house.Exceptions were made for two individuals,who were treated in their own homes. It is ouropinion that the results achieved were enhancedwhen done outside of the client’s residence. Theopportunity to have several days divorced fromthe demands and surroundings of daily life of-fers a better opportunity to process and inte-grate the ibogaine experience.The process began with an initial introduc-tion and consultation, during which the possiblerisks and potential benefits associated withibogaine treatment were discussed. If the outcomeresulted in the subject feeling that this was a suit-able treatment modality, he or she was required tosubmit to a liver function test and an ECG. Oncean informed decision had been made, and the re-ports of the liver and heart tests returned accept-able results, a session was scheduled..• Subject participation must be voluntaryand informed.• Subject must sign an informed consentindicating their understanding of the possiblerisks and potential benefits of ibogaine.• Subject must have done some researchand investigation into ibogaine and given somethought to the process.• Subject must obtain an ECG and report.• Subject must provide reports from a liverfunction test and blood work.• Subject must sign a form stating thatthey have not taken any narcotic analgesics,cocaine, amphetamines or alcohol for the last12 hours before arriving and that they have noneof these substances in their possession.• Subject must provide a next of kin in caseof emergency.